Biomarkers are the substances, which are present in blood, tissues or other body fluids and indicate an abnormal condition or a disease. These biomarkers recognise the presence of cancer in the body.
Researchers have found many new biomarkers, which are widely used for new treatment strategies resulting in precision medicine. Some of the major biomarkers include AFP (Liver Cancer), BCR-ABL (Chronic Myeloid Leukemia), BRCA1 / BRCA2 (Breast/Ovarian Cancer), CA-125 (Ovarian Cancer), PSA (Prostate Specific Antigen) (Prostate Cancer) and S100 (Melanoma).
- Track 1-1 Risks
- Track 2-2 Screening
- Track 3-3 Prognosis
- Track 4-4 Monitoring